Meeder Asset Management’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-198
Closed -$1.98K 622
2022
Q4
$1.98K Buy
+198
New +$2.2K ﹤0.01% 728
2021
Q3
Sell
-2,708
Closed -$59K 2478
2021
Q2
$59K Sell
2,708
-1,678
-38% -$33.9K ﹤0.01% 1066
2021
Q1
$90K Buy
+4,386
New +$86.6K ﹤0.01% 940
2018
Q3
Sell
-2,427
Closed -$122K 1537
2018
Q2
$122K Buy
2,427
+2,170
+844% +$95.6K 0.01% 590
2018
Q1
$10K Buy
257
+240
+1,412% +$7.36K ﹤0.01% 1057
2017
Q4
$0 Buy
+17
New +$401 ﹤0.01% 1652

Other funds holding AXGN

Meeder Asset Management's AXGN Position: Q1 2023 in Review

Meeder Asset Management sold out of Axogen (AXGN) in Q1 2023, closing a stake of 198 shares — an estimated $1.98K sold.

Meeder Asset Management first reported a position in AXGN in Q4 2017 and held it in 6 quarters. The position peaked at $122K in Q2 2018. 130 funds tracked by Wall St. Rank hold AXGN as of Q1 2023.

  • Meeder Asset Management reported no remaining Axogen position as of Q1 2023 after selling out during the quarter.
  • Meeder Asset Management sold 198 Axogen shares in Q1 2023, an estimated $1.98K.
  • Meeder Asset Management first reported a position in Axogen in Q4 2017 and held it in 6 quarters.
  • Meeder Asset Management's Axogen position peaked at $122K in Q2 2018.
  • 130 funds tracked by Wall St. Rank held Axogen as of Q1 2023.

Based on Meeder Asset Management's 13F filing for Q1 2023, filed 15 May 2023.